Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 5.42% institutional shareholders, 48.52% Rani Therapeutics Holdings insiders, and 46.06% retail investors. South Cone Investments Limited Partnership is the largest individual Rani Therapeutics Holdings shareholder, owning 18.73M shares representing 35.07% of the company. South Cone Investments Limited Partnership's Rani Therapeutics Holdings shares are currently valued at $37.83M.
If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.